Correlation Engine 2.0
Clear Search sequence regions


  • 2 complex (1)
  • bone marrow cells (1)
  • CSTA (19)
  • DAP12 (8)
  • DNAX (1)
  • glycoproteins (2)
  • M CSF (1)
  • mice (3)
  • osteoclast (10)
  • osteogenesis (2)
  • osteoporosis (5)
  • rank ligand (2)
  • RANKL (1)
  • receptor (3)
  • research (1)
  • signal (2)
  • TREM2 (7)
  • Tyrobp (1)
  • Sizes of these terms reflect their relevance to your search.

    Cystatin A (CSTA) is a cysteine protease inhibitor that is expressed highly during osteoporosis. However, the exact role of CSTA in osteoporosis remains unknown. In this study, we examined the role of CSTA in the formation, differentiation, and bone resorption of osteoclasts. We extracted bone marrow cells from 8-week-old wildtype mice to obtain RANKL and M-CSF-induced osteoclasts. We performed CSTA overexpression and knockdown experiments in the cells. We analyzed the role of CSTA in the process of osteoclasts by trap staining. In addition, we studied the contribution of CSTA to osteogenesis through the DAP12/TREM2 (DNAX-activating protein of 12 kDa/Triggering receptor expressed on myeloid cells-2) complex. We analyzed the role of CSTA in postmenopausal osteoporosis using OVX mouse models. We found that the silencing of CSTA inhibited the differentiation and formation of osteoclasts. The loss of CSTA weakened the expression of osteoclast marker genes. In contrast, overexpression of CSTA significantly increased differentiation and formation of osteoclasts and enhanced bone resorption. Immunofluorescence staining indicated that CSTA and DAP12 are co-expressed in osteoclasts, and the loss of either DAP12 or TREM2 inhibited osteoclast differentiation and bone resorption. Suppression of CSTA decreased DAP12 and TREM2 expression, whereas overexpression of CSTA rescued the loss of TREM2 expression caused by DAP12 knockdown. Co-immunoprecipitation and co-localization experiments indicated that CSTA interacted with DAP12. In addition, we found that injection of si-CSTA into OVX mice significantly improved bone parameters. Our research indicates that CSTA interacts with the DAP12/TREM2 complex and could be a potential targeted therapy for osteoporosis management. Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

    Citation

    Rui Wei, Lin Zhang, Wei Hu, Jie Wu, Wei Zhang. CSTA plays a role in osteoclast formation and bone resorption by mediating the DAP12/TREM2 pathway. Biochemical and biophysical research communications. 2022 Oct 30;627:12-20

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36007331

    View Full Text